Microbiome-based Therapeutics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
63
NCT06998043
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 2, 2025
Completion: Sep 30, 2026
Loading map...